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ActRI and TSR1/SKR3, have been shown to bind TGF-β e-mail: derynck@itsa.ucsf.edu when co-expressed with TβRII (Attisano et al., 1993; Ebner et al., 1993a; Franzén et al., 1993; Transforming growth factor-β (TGF-β) signals through 1994a). However, only TβRI mediates the induction of a heteromeric complex of related type I and type II gene expression and growth inhibition in response to serine/threonine kinase receptors. In Mv1Lu cells the TGF-β in Mv1Lu epithelial cells (Franzén et al., 1993 ; type I receptor TβRI mediates TGF-β-induced gene Bassing et al., 1994b; , while Tsk7L expression and growth inhibition, while the closely plays a role in TGF-β-induced differentiation in another related type I receptors Tsk7L and TSR1 are inactive epithelial cell line NMuMG (Miettinen et al., 1994) .
in these responses. Using chimeras between TβRI
Several structural features distinguish type I from type II and Tsk7L or TSR1, we have defined the structural receptors. In particular, type I receptors have a highly requirements for TGF-β signaling by TβRI. The extraconserved GS motif (SGSGSGLP) in the cytoplasmic cellular/transmembrane or cytoplasmic domains of juxtamembrane region immediately preceding the kinase TβRI and Tsk7L were functionally not equivalent. The domain (reviewed by Derynck, 1994b) . Deletion of this juxtamembrane domain, including the GS motif, and juxtamembrane domain abolishes the ability of TβRI most regions in the kinase domain can functionally to undergo autophosphorylation and to mediate TGF-β-substitute for each other, but the αC-β4-β5 region dependent intracellular responses , and from kinase subdomains III to V conferred a distinct single amino acid substitutions in the GS motif cause signaling ability. Replacement of this sequence in TβRI loss-of-function or gain-of-function mutations of TβRI by the corresponding domain of Tsk7L inactivated (Wieser et al., 1995) . These results suggest that the TGF-β signaling, whereas its introduction into Tsk7L conserved GS domain plays an important role in activating conferred TGF-β signaling. The differential signaling the type I receptor kinase (Wieser et al., 1995) and/or associated with this region was narrowed down to a probably in recruiting intracellular signaling components sequence of eight amino acids, the L45 loop, which is (Saitoh et al., 1996) . Furthermore, the extensive sequence exposed in the three-dimensional kinase structure and differences in the cytoplasmic juxtamembrane domains, diverges highly between TβRI and Tsk7L or TSR1.
but not in the rest of the cytoplasmic domain of the type Replacement of the L45 sequence in Tsk7L with that I receptors, suggest that they play a role in conferring of TβRI conferred TGF-β responsiveness to the Tsk7L signaling specificity to different ligands, possibly by cytoplasmic domain in Mv1Lu cells. Thus, the L45 interacting with different cytoplasmic effector proteins sequence between kinase subdomains IV and V specifies (Saitoh et al., 1996) . TGF-β responsiveness of the type I receptor. Feng and Derynck, 1996) , and ligand binding stabilizes this heteromeric association. In response Transforming growth factor-β (TGF-β) regulates cell to TGF-β binding, the cytoplasmic domains of the type I growth and differentiation (for recent reviews, see receptors are phosphorylated by the constitutively active Derynck, 1994a; Kingsley, 1994) by interacting with two and autophosphorylated type II receptor kinase (Wrana types of receptors, the type I and type II TGF-β receptors, et al., 1994; Chen and Weinberg, 1995) . This phosphorylwhich are both essential for signal transduction (Wrana ation of the type I receptor cytoplasmic domain occurs et al., 1994; and reviews by Derynck, 1994b; primarily in the juxtamembrane and conserved GS 1996). Both type I and type II receptors belong to domains Chen and Weinberg, 1995 ; an expanding family of transmembrane serine/threonine Souchelnytskyi et al., 1996) . Following activation of the kinases. While the type II TGF-β receptor, TβRII, binds type I receptor, the heteromeric receptor complex mediates TGF-β1 by itself, the type I receptor only binds TGF-β1 the biological responses of TGF-β, such as growth inhibiin the presence of TβRII, consistent with a physical tion and extracellular matrix production. Recent progress interaction of these two receptor types Feng and Derynck, 1996 ; and reviews by Derynck, strongly suggests that mammalian homologs of Drosophila Mad (mother against dpp) (Sekelsky et al., 1995) , recently expression responses. In contrast, Tsk7L and TSR1 do not signal these responses in Mv1Lu cells (Bassing et al., renamed Smads, are intracellular effectors of TGF-β 1994b; ten Dijke et al., 1994a; . receptor signaling To delineate the structural basis of the difference in 1996). Smad2 and Smad3 have been shown to associate ability of TβRI and Tsk7L to mediate the TGF-β responses, with the TβRI-TβRII receptor complex and to be phoswe made expression plasmids for chimeric receptors that phorylated (Macias-Silva et al., 1996; Zhang et al., 1996) . exchange domains of Tsk7L and TβRI. As a first step, we Furthermore, Smad2/3 associate with Smad4 and are constructed two chimeric type I receptors that combined translocated into the nucleus (Lagna et al., 1996;  Zhang the extracellular/transmembrane (ET) and cytoplasmic et al., 1996 Wu et al., 1997) . Ligand binding domains of TβRI and Tsk7L, thereby creating the receptor induces phosphorylation of Smads and nuclear translocahybrids TβRI-Tsk7L and Tsk7L-TβRI (Figure 2A ). These tion (Macias-Silva et al., 1996) . In the nucleus, Smads chimeric receptors, which were C-terminally FLAG are thought to function as transcriptional activators for tagged, were expressed with their expected molecular TGF-β-responsive genes (Liu et al., 1996) . weights and at levels similar to the parental receptors in To gain insight into the role of TβRI in TGF-β-mediated transfected R1B-L17 cells. Both chimeric receptors were responses, we characterized the structural requirements able to bind [ 125 I]TGF-β when co-expressed with TβRII, for the function and signaling specificity of type I receptors.
Introduction
although the ligand binding to the TβRI ET domain was As a model, we compared TβRI, which mediates TGF-β-stronger than to the Tsk7L ET domain ( Figure 2B ). Thus, induced growth inhibition and expression of plasminogen the mutant receptors, like the wild-type receptors, were activator inhibitor type 1 (PAI-1) in Mv1Lu epithelial readily expressed at the cell surface and displayed normal cells, with the related Tsk7L receptor, which does not ligand binding. induce these responses. We made chimeric receptor
The signaling potential of these chimeric receptors was mutants between TβRI and Tsk7L and analyzed their assessed in R1B cells (Laiho et al., 1990 (Laiho et al., , 1991 ) using ability to rescue TGF-β responsiveness in Mv1Lu-R1B both the cyclin A-luciferase and PAI-1-luciferase reporter cells which lack functional TβRI. In R1B cells, TβRI but assays . Expression of TβRI, but not not Tsk7L rescues TGF-β-induced growth inhibition and Tsk7L, restored responsiveness to TGF-β in transfected gene expression responses. Our results demonstrate that R1B cells ( Figure 2C ), consistent with previous findings in the cytoplasmic domain, the juxtamembrane domain that TβRI, but not Tsk7L, mediates the effect of TGF-β (including the GS motif) and most regions in the kinase on transcription of both cyclin A and PAI-1 (Feng et al., domain are functionally equivalent in the two type I 1995). However, neither of the chimeric receptors conreceptors. However, the αC-β4-β5 region, in particular ferred TGF-β responsiveness in R1B cells. This suggests the L45 loop between the β4 and β5 strands, determined that the ET domain of TβRI plays a role in TGF-β signal the signaling capacity of TβRI. Significantly, mutation transduction which cannot be replaced by the Tsk7L ET of this sequence of TβRI dramatically decreased the domain. Furthermore, the inactivity of Tsk7L in TGF-β signaling capacity of TβRI, and introduction of the L45 signaling is not only associated with its ET domain but sequence of TβRI into Tsk7L conferred TGF-β-induced also with its cytoplasmic domain, since TβRI-Tsk7L did signaling activity to this otherwise inactive receptor. Our not mediate TGF-β responses, despite its close structural results show that the L45 loop defines the signaling similarity with TβRI. specificity of the type I receptor for TGF-β intracellular
We also determined the in vitro kinase activity of the responses. receptors and their hybrids. As shown in Figure 3 , TβRI had strong kinase activity (lane 2), while the kinase activity of Tsk7L was weak (lane 3). The cytoplasmic juxtamembrane domain and the between TβRI and TSR1, and 24% between Tsk7L and kinase subdomains I-II of TβRI can be replaced by TSR1. The cytoplasmic domains of these receptors demonthe corresponding sequences of Tsk7L strate a much higher sequence similarity and identity, Our results with the two chimeras strongly suggest that consistent with the conserved sequence requirements of the cytoplasmic domain of the type I receptor determines the large serine/threonine kinase domains. The sequences the signaling specificity of TGF-β receptors, since replaceof the cytoplasmic domains of the three type I receptors ment of the cytoplasmic domain of TβRI with the closely are 73-83% similar (60-73% identical) (Figure 1 ). In related domain of Tsk7L abolishes TGF-β signaling. The spite of their sequence conservation and ability to bind cytoplasmic domains of TβRI and Tsk7L, as well as of TGF-β1, these type I receptors have different signaling TSR1, show extensive sequence identity over the 11 kinase functions and specificities. In Mv1Lu epithelial cells, the subdomains (as defined by Hanks et al., 1988 ) that most frequently used TGF-β-responsive cell system, only comprise most of the cytoplasmic domain (Figure 1 ). Some sequence differences are scattered over the different TβRI transduces TGF-β-induced antiproliferative and gene Hanks et al. (1988) . Secondary structure assignments for type I receptors were obtained from comparison with cAPK (Knighton et al., 1991) and IRK (Hubbard et al., 1994) . Secondary structures are shown only in and around the subdomain II and V: α, α-helix; β, β-strands; L, loop.
subdomains, but the most notable differences are in the sequences comprise the divergent juxtamembrane domain and the conserved GS domain that is a target for phosjuxtamembrane domain immediately upstream from the conserved GS motif that defines the type I receptors.
phorylation by TβRII Chen and Weinberg, 1995; Souchelnytskyi et al., 1996) , as well as These juxtamembrane sequences of~40 amino acids long have only minimal sequence similarity.
the kinase subdomains I-II. Thus, neither the juxtamembrane nor GS domains define the differential signaling To determine which cytoplasmic sequences conferred TGF-β signaling, we made several chimeric receptors in abilities of the two type I receptors. In contrast, extending the replaced sequences into kinase subdomain V, as in which defined fragments of the cytoplasmic domain of TβRI were replaced by the corresponding sequences of TβRI-Tsk7L Swap C3, abolished the ability to mediate TGF-β signaling in R1B cells ( Figure 4B ), suggesting that Tsk7L. We first concentrated on the highly divergent juxtamembrane domains by making expression plasmids the kinase subdomains III-V may play a role in defining the signaling specificity. for three chimeric receptors, named Swap C1, C2 and C3 ( Figure 4A ). In these chimeras, the TβRI sequences Since the chimeric receptors were expressed at similar levels, the differential signaling abilities could not be starting at amino acid 149 and extending to residues 202, 234 and 284 for Swap C1, C2 and C3, respectively, were explained by inadequate expression of Swap C3 ( Figure 3 , lanes 6-8). Furthermore, the immunoprecipitated receptors replaced by the corresponding Tsk7L sequences. These chimeric receptors were expressed at similar levels in were able to autophosphorylate in vitro, albeit with somewhat different efficiencies. The wild-type Tsk7L receptor transfected cells (Figure 3 , lanes 6-8) but displayed different abilities to mediate TGF-β signaling. As shown and Swap C1 had very low in vitro kinase activity when compared with TβRI ( Figure 3 , lanes 2, 3 and 6, lower in Figure 4B , Swap C1 and C2, but not Swap C3, restored TGF-β signaling in R1B cells as scored in both reporter panel). Thus, the similar biological activities of TβRI and Swap C1 indicate a lack of correlation between the assays, similarly to TβRI. These results demonstrate that the first 86 amino acids (i.e. amino acids 149-234 of biological and kinase activities. Accordingly, the biological inactivity of Swap C3 did not correlate with an inability TβRI) in the cytoplasmic domain are functionally indistinguishable between the two type I receptors. The replaceable to autophosphorylate ( Figure 3 , lane 8, lower panel). The C-terminal segment, i.e. subdomains VI-XI, of sequences. In Swap C4, this substitution comprised the C-terminal tail and kinase subdomains IX, X and XI, the cytoplasmic domain of TβRI can be replaced by Tsk7L sequences while the replacement of the C-terminal segment in Swap C5 was extended into kinase subdomain V. The chimeric To examine further the functions of C-terminal kinase subdomains of TβRI, we generated expression plasmids receptors, Swap C4 and C5, were as active as TβRI in both the PAI-1 and cyclin A assays in transfected R1B for additional receptor chimeras in which increasingly longer C-terminal segments of TβRI were replaced by cells ( Figure 5B ). In contrast, two other chimeras, i.e. Swap C6 and C7, were unable to signal TGF-β responses Tsk7L sequences. As shown in Figure 5A , TβRI-Tsk7L Swap C4 and C5 had the C-terminal 119 and 217 amino in these assays ( Figure 5B ). These two chimeras contained larger C-terminal segments of Tsk7L, including part of acids, respectively, replaced by the corresponding Tsk7L in Figure 2C . cells in both the PAI-1-and cyclin A-luciferase reporter assays, presented as in Figure 2C .
(amino acids 235-383), respectively, replaced by Tsk7L sequences ( Figure 6A ). Both Swap C8 and C9 were unable kinase subdomain III and all downstream sequences in the case of Swap C6, and the entire kinase domain of to mediate TGF-β responsiveness in transfected R1B cells ( Figure 6B ). This result is consistent with the requirement Tsk7L in the case of Swap C7. The abilities of Swap C4 and 5 to mediate TGF-β signaling and the inactivity of of kinase subdomains III-V (amino acids 235-284) of TβRI for TGF-β signaling (Figures 4 and 5) . Swap C6 and C7 in these assays suggested an important role of kinase subdomains IV and V in mediating TGF-β
The amino acid sequences of the αC-β4-β5 regions (amino acids 235-284 in TβRI) of TβRI and Tsk7L show signaling by TβRI. The kinase activity of the immunoprecipitated receptors was thus tested in vitro. As shown 68% identity (Figure 1 ). Within this segment, a stretch of nine amino acids, which we will name the L45 sequence in Figure 3 (lower panel, lanes 9-12), only Swap C4 demonstrated a high autophosphorylation activity, while (amino acids 263-271 of TβRI), are different between the two receptors, with the exception of a conserved Asp Swap C5, C6 and C7 had minimal activity in this assay. Thus, there was again no correlation between the signaling (Figure 1 ). Furthermore, this short sequence in Tsk7L is nearly identical to the L45 sequence in the TSR1 type I ability and kinase activity of these swap receptors.
receptor, which is, similarly to Tsk7L, also inactive in TGF-β transcriptional responses in Mv1Lu cells (Attisano The L45 sequence loop of the TβRI kinase domain is essential for signaling et al., 1993) .
To investigate the role of the L45 sequence, we generOur results described above suggested the importance of amino acids 235-284 in defining the signaling activity of ated two TβRI mutants. In TβRI Tsk7L(αCβ45) , the αC-β4-β5 region of TβRI (amino acids 235-284) was substituted TβRI. This sequence is located within subdomains III, IV and V of the kinase and corresponds in the three-dimenwith the corresponding Tsk7L sequence and, in TβRI Tsk7L(L45) , only the L45 loop of TβRI (amino acids sional structure of cAMP-dependent protein kinase to a region containing two β strands (named the αC-β4-β5 263-271) was mutated into the corresponding Tsk7L sequence ( Figure 7A ). In R1B cells, the signaling ability region) (Knighton et al., 1991) . Based on our results, we predicted that replacement of kinase subdomains IV and of both mutant receptors was only minimal when compared with TβRI. While TGF-β increased PAI-1-luciferase V in TβRI with the corresponding sequences of Tsk7L would inactivate the signaling activity of TβRI. To test activity~10-fold in TβRI-expressing R1B cells, this activity was only marginally (Ͻ2-fold) increased in cells this prediction, we constructed two additional chimeric receptors, named Swap C9 and C8, which had a central that expressed TβRI Tsk7L(αCβ45) or TβRI Tsk7L(L45) ( Figure  7B , left panel). The ability of TβRI Tsk7L(αCβ45) and region of the TβRI cytoplasmic domain replaced by Tsk7L sequences. TβRI-Tsk7L Swap C9 and Swap C8 had kinase TβRI Tsk7L(L45) to mediate TGF-β-induced inhibition of cyclin A-luciferase expression was also marginal ( Souchelnytskyi et al., 1996) . However, the in vitro kinase activities of TβRI Tsk7L(L45) and TβRI Tsk7L(αCβ45) (data not shown) were considerably lower this chimera TβRI-Tsk7L TβRI(αCβ45) was active not only in the PAI-1 but also in the cyclin A reporter assay than that of TβRI ( Figure 8C, compare lanes 2 and 3) .
(data not shown), we expected that TGF-β treatment of transfected R1B cells expressing TβRI-Tsk7L TβRI(αCβ45) Inactive type I receptor cytoplasmic domains can be converted into TGF-β signal-transducers would result in inhibition of DNA synthesis. Indeed, expression of either wild-type TβRI or TβRI-Our experiments, described above, revealed that most regions in the cytoplasmic domains of the type I receptors, Tsk7L TβRI(αCβ45) in R1B-L17 cells reduced the [ 3 H]thymidine incorporation by 36-40% in the presence of TGF-β. with the exception of the αC-β4-β5 region, in particular the L45 loop, are functionally equivalent for TGF-β Considering the transfection efficiency of 40-60%, this would correspond to an inhibition of DNA synthesis of signaling. This finding raised the possibility that a type I receptor that is inactive in the TGF-β signaling assays~60-90% in response to TGF-β. In constrast, DNA synthesis was not inhibited in cells expressing TβRI-Tsk7L can be converted into an active receptor merely by replacing its αC-β4-β5 region with that of TβRI. We or in control-transfected cells lacking TβRI ( Figure 9C ). To evaluate further the ability of the αC-β4-β5 region thus introduced the αC-β4-β5 region of TβRI (amino acids 235-284) into TβRI-Tsk7L, thereby generating of TβRI to confer TGF-β signaling ability in our assays, we introduced this sequence into the cytoplasmic domain the receptor chimera TβRI-Tsk7L TβRI(αCβ45) (Figure 9A ). Although the original chimera TβRI-Tsk7L was unable to of TSR1/SKR3 (Attisano et al., 1993) , which like Tsk7L does not mediate TGF-β-induced gene expression and restore the TGF-β-induced PAI-1 and cyclin A responses, TβRI-Tsk7L TβRI(αCβ45) mediated TGF-β signaling to an growth arrest in Mv1Lu cells (Attisano et al., 1993; Bassing et al., 1994b) . Thus, amino acids 235-284 of extent that was comparable with TβRI ( Figure 9B ). Since Figure 2C . Figure 2C .
receptors in R1B cells in the PAI-1-luciferase reporter assay, presented as in Figure 2C .
TβRI were introduced into the corresponding region of TβRI-TSR1, a hybrid receptor which contains the extrainactive receptor chimeras with the corresponding TβRI sequence is sufficient to convert these into receptors cellular and transmembrane domain of TβRI and the cytoplasmic domain of TSR1, thereby generating chimera capable of transducing TGF-β signals. Both the signalinginactive TβRI-Tsk7L and -active TβRI-Tsk7L TβRI(L45) TβRI-TSR1 TβRI(αCβ45) ( Figure 9A ). Similarly to TSR1, TβRI-TSR1 was completely inactive in mediating TGF-β-were able to form a ligand-induced complex with TβRII ( Figure 8A , lanes 4 and 5) and were similarly phosphorylinduced PAI-1 ( Figure 9D ) and cyclin A responses (data not shown) in R1B cells. In constrast, TβRI-ated in vivo ( Figure 8B , lanes 4 and 5). However, their in vitro kinase activity was minimal ( Figure 8C , lanes 4 TSR1 TβRI(αCβ45) was able to mediate a PAI-1-luciferase response following treatment with TGF-β, albeit to a and 5, data not shown). Therefore, introduction of the TβRI αC-β4-β5 or L45 into the Tsk7L kinase domain did lesser extent than TβRI ( Figure 9D ). These results further emphasize the essential role of the αC-β4-β5 region of not enhance its interaction with TβRII and phosphorylation either in vivo and in vitro. TβRI in TGF-β signaling and its ability to confer TGF-β signaling specificity to otherwise inactive type I receptors.
Discussion

The L45 region of TβRI is sufficient to confer the ability of heterologous type I receptor cytoplasmic
The receptors for TGF-β-related factors are transmembrane serine/theronine kinases, classified as type I and type II domains to transduce TGF-β signals Our results suggested that the nine amino acid long receptors based on their structural and functional characteristics. The type II TGF-β receptors form homo-oligomers L45 sequence of TβRI was essential for TGF-β signal transduction by TβRI and that this loop might be the in the absence of ligand and are constitutively autophosphorylated Henis et al., 1994 ; motif that determines the intracellular signaling specificity. We therefore made derivatives from the receptor chimeras Luo and Lodish, 1996) . Type II receptor homo-oligomers interact with type I receptor homo-oligomers to form a TβRI Tsk7L(αCβ45) and TβRI-Tsk7L, in which the L45 sequence of Tsk7L was mutated back into the correspondhetero-oligomeric complex that is stabilized by ligand binding ; Weis-Garcia and ing TβRI sequence ( Figure 10A , hybrids 3 and 6). These mutant receptors, named TβRI Tsk7L(αCβ45)/TβRI(L45) and Massague, 1996) . The physical association of both receptor types, the phosphorylation of the type I receptor cyto-TβRI-Tsk7L TβRI(L45) , had signaling abilities in response to TGF-β that were similar to TβRI ( Figure 10B ). Thus, plasmic domains by type II receptor kinases and the requirement of both receptor types for full responsiveness replacement of only eight amino acids in the L45 loop of to TGF-β strongly suggest that the heteromeric receptor importance for type I receptor function, and point mutations of this sequence in TβRI modify the signaling complex represents the signaling unit for the multiple responses to TGF-β and related factors (Wrana et al., ability of the type I receptor (Brand and Schneider, 1995; Wieser et al., 1995) . The juxtamembrane domain of 1992, 1994; Franzén et al., 1993; Bassing et al., 1994a; Okadome et al., 1994; Chen and Weinberg, 1995; TβRI also contains a phosphorylation site at Ser165 (Souchelnytskyi et al., 1996) , which is absent in the et al., 1995) . In this signaling receptor complex, the type I receptor defines the intracellular signaling specificity corresponding Tsk7L and TSR1 region (Figure 1 ). Since the juxtamembrane domain is the only region of any (Cárcamo et al., 1994) , although the mechanism and structural basis for the signaling specificity of the type I length that is located outside the kinase domain, it has been proposed that this region represents a docking site for receptors is not understood. In this study, we have evaluated the sequence requirements that determine the ability interacting cytoplasmic proteins that defines the signaling specificity (Saitoh et al., 1996) . This would then resemble of TβRI to mediate TGF-β signaling. We have found that a nine amino acid sequence, the L45 loop, in the kinase the activation mechanism of tyrosine kinase receptors, with which cytoplasmic effector proteins associate at domain of the type I receptor defines the TGF-β signaling specificity.
sequences outside the kinase subdomains (for a review, see Schlessinger and Ullrich, 1992) , and would be consistent with the high degree of sequence divergence among the Most regions in the cytoplasmic domains of TβRI and Tsk7L are functionally exchangeable juxtamembrane domains of type I receptors. Furthermore, deletion of this juxtamembrane domain inactivated TGF-β To define the structural basis for the TGF-β signaling ability of TβRI, we exchanged corresponding domains signaling by TβRI in reporter assays , and deletion of a shorter segment, i.e. amino acids 150-between two related type I receptors, TβRI and Tsk7L, and tested the signaling of the resulting receptor hybrids 181 of TβRI, abolished TGF-β-induced growth inhibition but not gene expression in response to TGF-β (Saitoh in response to TGF-β. TβRI mediates TGF-β signaling in a variety of cell types, including Mv1Lu epithelial cells et al., 1996) . The signaling phenotype of the latter deletion mutant is, however, consistent with an impaired signaling (Franzén et al., 1993; Bassing et al., 1994b; . In contrast, Tsk7L and the related TSR1 receptor ability of the resulting receptor and with different thresholds of signaling required to transduce the gene expression do not mediate TGF-β responsiveness in Mv1Lu cells and cannot substitute for TβRI to transduce TGF-β signals in and growth arrest responses . Thus, a decreased signaling ability of the receptor is expected R1B cells (Attisano et al., 1993; Bassing et al., 1994b; . Nevertheless, both receptors bind first to inactivate the growth inhibition response, as the induction of gene expression still occurs at lower levels TGF-β when co-expressed with TβRII (Attisano et al., 1993; Ebner et al., 1993b) , although they also have the of receptor activation . Taken together, previous reports certainly emphasize the critical role of ability to bind activin (Attisano et al., 1993; Ebner et al., 1993b) and, in the case of Tsk7L, BMP-7 (ten Dijke et al., the juxtamembrane domain in receptor signaling, but our current findings strongly argue against a role for this 1994b). However, dominant-negative interference studies strongly suggest a role for Tsk7L in TGF-β-induced segment in defining the signaling specificity and in recruiting intracellular proteins that mediate differential epithelial to mesenchymal transdifferentiation, but not in other TGF-β responses, of NMuMG mammary epithelial responses. Furthermore, the TβRII-induced phosphorylation at Ser165 which occurs in TβRI (Souchelnytskyi cells (Miettinen et al., 1994) . This further suggests that different type I receptors may mediate different TGF-β et al., 1996) , but not in Tsk7L and TSR1, may not be essential for the signaling activity. responses in various cell types.
The hybrid receptors, in which the entire ET or cytoOur functional analyses showed that most kinase subdomains of TβRI are functionally replaceable with the plasmic domains were exchanged between TβRI and Tsk7L, were both unable to mediate TGF-β responsivecorresponding sequences of the Tsk7L receptor. However, replacement of the kinase subdomains IV and V of TβRI ness. The inability of the Tsk7L-TβRI chimera to transduce TGF-β signals may be due to a conformational difference with those of Tsk7L inactivated TGF-β signaling, and substitution of those sequences in Tsk7L with the corresfrom wild-type TβRI which may be reflected in the weak binding of TGF-β to Tsk7L ligand-binding domain, while ponding segment of TβRI conferred the ability to mediate TGF-β signaling. These sequences provide a defined that of the reverse chimera TβRI-Tsk7L suggests the inability of the Tsk7L cytoplasmic domain to mediate region consisting of an α-helix followed by two β-strands, named the αC-β4-β5 region in the three-dimensional TGF-β-dependent PAI-1 and cyclin A responses. Thus, the lack of TGF-β signaling of Tsk7L in these assays structure of kinases, as defined by crystallographic analysis of the cAMP-dependent protein kinase (Knighton et al., may be associated with properties of both its ET and cytoplasmic domains. 1991) and several other kinases (De Bondt et al., 1993; Hubbard et al., 1994) . Thus, this sequence of~50 amino The differential ability of the TβRI and Tsk7L cytoplasmic domains to mediate TGF-β signaling allowed us acids in the kinase subdomains IV and V plays a critical role in TGF-β signaling by TβRI. to characterize the structural basis for this functional difference. Most subdomains in the cytoplasmic domain of TβRI can be replaced with the corresponding portions The L45 region in kinase subdomains IV and V as determinant of TGF-β signaling specificity of Tsk7L. Most notable is our observation that the juxtamembrane and GS domains of both TβRI and Tsk7L
The αC-β4-β5 regions of TβRI and Tsk7L share 68% sequence identity. In this region of TβRI, amino acids receptors are functionally equivalent in TGF-β signaling. The GS domain is highly conserved and of critical 263-271, which form the L45 loop, are highly divergent ability to mediate TGF-β signaling correlates with the kinase activity of the type I receptors. This appears to be in agreement with our results that the in vitro kinase activity of the Tsk7L kinase is much lower than that of TβRI. However, several chimeras with high kinase activity were unable to mediate TGF-β signaling in our assays, as other chimeras that mediated TGF-β responsiveness in our assays had only a low level of kinase activity comparable with Tsk7L. Although replacement of the αC-β4-β5 region or only the L45 loop sequence of TβRI with the corresponding sequences of Tsk7L decreased the kinase activity in vitro, introduction of the αC-β4-β5 region of TβRI into the Tsk7L or TSR1 kinase domain did not enhance the in vitro kinase activity of chimeric receptors, yet conferred a significant TGF-β signaling activity. For example, the TβRI-Tsk7L TβRI(L45) receptor hybrid has a much lower kinase activity thanTβRI, yet its signaling activity was comparable with that of TβRI. We therefore conclude that the signaling activity of the different hybrids did not correlate with the kinase activity in vitro.
Another possibility would be that the differential ability of the type I receptor hybrids to mediate TGF-β signaling might be associated with differences in activation by the type II receptor kinase, whereby receptor chimeras lacking the L45 loop sequence of TβRI would be defective in activation. Activation-defective type I receptors are unable to mediate TGF-β signaling, similarly to kinase-defective mutants, but co-expression of these two types of inactive Garcia and Massagué, 1996) . However, co-expression of overall similarity in three-dimensional structures of protein kinases our TGF-β signaling-defective chimeras with the kinase- (Hanks and Hunter, 1995) , the L45 of TβRI corresponds to the loop defective TβRI (K230R) mutant did between the β-strands 4 and 5. The amino acid sequence of the L45 loop of TβRI is shown. not result in signaling activity due to complementation in R1B cells ( Figure 7B ), indicating that they are not activation-defective mutants. In addition, we did not observe from the corresponding sequences in the Tsk7L and TSR1 receptors, strongly suggesting that this sequence might be any differences in TGF-β-induced association of the signaling-defective TβRI-Tsk7L and the active TβRI-critical in TGF-β signaling and responsible for the functional difference between TβRI and Tsk7L or TSR1.
Tsk7L TβRI(L45) with TβRII, when compared with TβRI, suggesting that the nature of the L45 does not interfere Indeed, the mutant TβRI receptors TβRI Tsk7L(αCβ45) and TβRI Tsk7L(L45) in which the αC-β4-β5 and L45 sequence with the heteromeric receptor association. Furthermore, the nature of the L45 sequence did not detectably affect were replaced by Tsk7L sequences, respectively, were unable to mediate TGF-β responsiveness. In complementthe in vivo phosphorylation of TβRI, which is thought to result from the constitutive kinase activity of TβRII. ary experiments, introduction of the αC-β4-β5 region or even only the eight divergent amino acids of the L45 loop Therefore, it is unlikely that the L45 region of TβRI is involved in an interaction with and transphosphorylation of TβRI into the Tsk7L cytoplasmic domain conferred TGF-β signaling activity to this otherwise inactive recepand activation by TβRII. Protein kinases display conservation in amino acid tor, to a similar extent as wild-type TβRI. Similarly, the αC-β4-β5 region or only the L45 loop of TβRI also sequences clustered in several subdomains. In the catalytic core with its striking sequence conservation, most amino conferred an ability to mediate TGF-β signaling to the TSR1 cytoplasmic domain. Thus, the L45 loop of TβRI acids contribute directly to ATP binding or catalysis. However, the recognition and binding of substrate proteins is essential and sufficient to confer the ability to mediate TGF-β signaling to another type I receptor cytoplasmic involve many other sequences that are not necessarily conserved at the surface of the kinase. For example, a domain.
The mechanistic basis for this essential role of the αC-sequence in the kinase subdomain III of cAMP-dependent protein kinase, which corresponds to a loop between the β4-β5 region, and in particular the L45 sequence, in TGF-β signaling is as yet unclear. However, the three-β3 strand and helix C, interacts with the regulatory RI subunit (Cox and Taylor, 1994) , whereas, in cyclindimensional protrusion of the L45 loop carried by the β4 and β5 strands in the three-dimensional structure of the dependent kinases, this loop is involved in binding of cyclins (Ducommun et al., 1991; De Bondt et al., 1993) . kinase strongly suggests that it is sterically accessible and structurally sensitive to alterations of a few amino acids No function has as yet been attributed to the L45 loop in the αC-β4-β5 region of any kinases. However, the ( Figure 11 ). One possible mechanism would be that the medium was changed every 3 days. Mv1Lu mink lung epithelial cells location of the L45 loop on the surface of the protein ATCC) 1996; Zhang et al., 1996) . An involvement of the αC- et Okadome et al., 1996; Wang et al., 1996) .
Lysates were pre-cleared in a mixture of rabbit anti-mouse IgG (Jackson However, the L45 sequence might play an essential Laboratories) and protein A-Sepharose CL4B (Pharmacia), and immunoprecipitated using the monoclonal antibodies 9E10 (anti-myc) or M2 role in the selectivity of interacting proteins and in the (anti-FLAG, Kodak). Immunoprecipitated proteins were subjected to specificity of intracellular signaling. Thus, the L45 loop, electrophoresis on SDS-PAGE and visualized by autoradiography.
which defines the ability to mediate TGF-β signaling of For in vitro kinase assays, immunoprecipitated proteins was incubated the type I receptor, may serve as a docking site for specific at room temperature for 30 min in 1ϫ kinase buffer (10 mM HEPES-KOH, pH 7.5, 5 mM MgCl 2 and 5 mM CaCl 2 ) containing 5 μCi of intracellular signaling mediators or substrates which asso- region should provide additional insights into the signaling COS-1 cells were transfected, with one or several expression plasmids for a single receptor, as described above for immunoprecipitation. Forty mechanism of TGF-β receptors.
eight hours after transfection, COS-1 cells were cross-linked with 125 Ilabeled TGF-β1 (Amersham) as described (Gazit et al., 1993) .
Materials and methods
Functional assays Construction of chimeric and mutant type I receptors
Plasmid p800Luc contains the luciferase reporter gene under the control Expression plasmids encoding the FLAG-tagged type I receptors TβRI of the TGF-β-responsive promoter for plasminogen activator inhibitor and Tsk7L have been described previously and were type I (PAI-1) (Keeton et al., 1991) and was used to monitor TGF-β-used as parental plasmids to create the chimeric and mutant type I induced gene expression. The cyclin A-luciferase reporter plasmid receptors. The domains of the receptors that were fused to create the pCAL2 was used to assay for TGF-β-induced growth inhibition. Plasmid chimeric receptors were obtained in most cases by amplification using pRKβGal, which expresses β-galactosidase under the control of the PCR methodology and/or by restriction digestion of receptor cDNAs. In cytomegalovirus promoter, was used to normalize for transfection efficithe latter case, we took advantage of the presence of several restriction ency. Plasmids pCAL2 and pRKβGal have been described elsewhere sites, e.g. one BamHI and two XbaI sites, in TβRI and the conservation . in amino acid sequences derived from these sites of Tsk7L. Since no
The reporter assays were performed in transient transfection assays restriction sites were available or could be created without altering the of Mv1Lu-R1B cells, whereby the receptor expression plasmids and amino acid sequence at the junction of the cytoplasmic juxtamembrane reporter plasmids are co-transfected . The luciferase domain and the kinase domain, we developed a modified PCR method expression levels were carried out using Analytic Luminescence Laborawhich we named 'Fusion PCR'. To construct TβRI-Tsk7L chimera C7 tory's assay reagents, and β-galactosidase was assayed in Galacto Light (see Figure 5A ), we designed a primer, GTTCAGAGAACAATTGCGPlus kit (Tropix). Both luciferase and β-galactosidase activities were AGAACTATAACCCTGTTGGAGTGTGTC, whose first half is from TβRI measured in a Luminometer Monolight 2010 (Analytic Luminescence (amino acids 197-204) and second half (shown in italics) from Tsk7L Laboratory). The luciferase activities which reflect the promoter activity (amino acids 208-214). Amplification of Tsk7L using this primer and a of cyclin A or PAI-1 were normalized to β-galactosidase expression. C-terminal reverse primer (GGCAGTCGACACAGTCAGTCTTCAAT-TTGTC; underlining indicates the incorporated SalI site) gave a product that a contained a small portion of TβRI (amino acids 197-204) followed by Tsk7L (amino acids 208-509). Use of this product as the reverse
